<DOC>
	<DOCNO>NCT02182635</DOCNO>
	<brief_summary>The objective study investigate long-term safety Ba253BINEB . Secondarily long-term efficacy Ba253BINEB also investigate .</brief_summary>
	<brief_title>Ba253BINEB Patients With Chronic Obstructive Pulmonary Disease ( COPD )</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Oxitropium</mesh_term>
	<criteria>The patient COPD ( chronic bronchitis , emphysema ) satisfy follow criterion 1 . Patients FEV1.0/FVC ( Forced vital capacity ) &lt; = 70 % screen test whose symptom stable 2 . Patients age &gt; = 40 year old 3 . Patients must able understand patient information form 1 . Patients complicate bronchial asthma , make assessment drug efficacy COPD difficult 2 . Patients take long acting corticosteroid ( i.m . ) within 1 month study 3 . Patients use oral corticosteroid medication dose excess equivalent 5 mg/day prednisolone 4 . Patients glaucoma 5 . Patients prostatic hypertrophy 6 . Patients hypersensitivity anticholinergic drug 7 . Patients serious hepatic disease , kidney disease heart disorder judge investigator inappropriate subject study 8 . Women pregnant may become pregnant , nursing woman 9 . Patients judge investigator inappropriate subject study</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>